TR
Transgene S.A.
TRGNF · OTC
$1.00 +0.00% (+$0.00)
Market Cap 114.2M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
3 /100
Expensive P/B 7.51x
P/S 17.97x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 16.80%
Rev. growth 38.28%
FCF growth N/A
Profitability
0 /100
Weak Net margin 534.72%
Op. margin 561.28%
FCF margin 419.06%
Quality
3 /100
Poor ROA 80.55%
Asset turnover 0.15x
ROIC 125.69%
Debt
67 /100
Low Current ratio 1.48x
Int. coverage -16.62x
Net debt/EBITDA 0.24x
Stability
46 /100
Moderate Rev. volatility 178.09%
EPS volatility 30.20%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TRGNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alessandro Riva
Employees
156
Headquarters
Illkirch-Graffenstaden
Evenimente viitoare
24 SEPT.
Earnings
Upcoming earnings report